CytoSorbents Corp. (CTSO)

0.643 0.00 (0.00%) USD  |  NASDAQ  |  Dec 17, 16:00
0.643 0.00 (0.00%) After-Hours: 18:34
More

CytoSorbents Research and Development Expense (Annual): 6.916M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for CTSO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Delcath Systems, Inc. 13.87M
Star Operating Cos., Inc. --
EXACT Sciences Corp. 431.21M
Illumina, Inc. 1.167B
Natera, Inc. 404.14M